Dr Lonnie Swift

Publications

D.R. Phillips, L.P. Swift, K.E. Coldwell, D.M.S. Spencer, R. Bilardi, B.J. Evison, O. Mansour, A. Nudelman, A. Rephaeli, T.H. Koch and S.M. Cutts, 'Drug-DNA Adducts formed by formaldehyde activation of anthracyclines and related anti-cancer agents', in E. Alvarez and R. Cunha (eds), DNA Adducts: Formation, Detection and Mutagenesis, Nova Publishing, 2010

K. Kimura, D.M.S. Spencer, R. Bilardi, L.P.Swift, A.J. Box, R.T.C. Brownlee, S.M. Cutts and D.R. Phillips, 'Barminomycin, a model for the development of new anthracyclines', Anti-cancer Agents in Medicinal Chemistry [Review], 2010, 10:70-77

I. Levovich, A. Nudelman, G. Berkovitch, L.P. Swift, S.M. Cutts, D.R. Phillips and A. Rephaeli, 'Formaldehyde-releasing HDAC inhibitor prodrugs specifically affect cancer cells by a ROS-dependent mechanism', Cancer Chemotherapy and Pharmacology, 2008, 62:471-82

L.P. Swift, A. Nudelman, I. Levovich, A. Rephaeli, S.M. Cutts and D.R. Phillips, 'The topoisomerase II catalytic inhibitor sobuzoxane enhances doxorubicin-DNA adduct mediated cytotoxicity', Cancer Chemotherapy and Pharmacology, 2008, 61:739-49

S.M. Cutts*, L.P. Swift*, V. Pillay, R. Forrest, A. Nudelman, A. Rephaeli and D.R. Phillips, 'Activation of clinically used anthracyclines by the formaldehyde-releasing prodrug Pivaloyloxymethyl butyrate', Molecular Cancer Therapeutics, 2007, 6:1450-59 [* equal first authors]

L.P. Swift, A. Rephaeli, A. Nudelman, D.R. Phillips and S.M. Cutts, 'Doxorubicin-DNA adducts induce a non-topoisomerase II mediated form of cell death', Cancer Research, 2006, 66:4863-71

S.M. Cutts, L.P. Swift, A. Rephaeli, A. Nudelman and D.R. Phillips, 'Recent advances in understanding and exploiting the activation of anthracyclines by formaldehyde', Current Medicinal Chemistry - Anti-Cancer Agents, 2005, 5:431-47

S.M. Cutts, L.P. Swift, A. Rephaeli and D.R. Phillips, 'Sequence specificity of Adriamycin-DNA adducts in human tumor cells', Molecular Cancer Therapeutics, 2003, 2:661-70

L.P. Swift, S.M. Cutts, A. Rephaeli, A. Nudelman and D.R. Phillips, 'Activation of Adriamycin by the pH dependent formaldehyde-releasing prodrug hexamethylenetetramine', Molecular Cancer Theraputics, 2003, 2:189-98

S.M. Cutts, B.S. Parker, L.P. Swift, K.I. Kimura and D.R. Phillips, 'Structural requirements for the formation of anthracycline-DNA adducts', Anticancer Drug Design, 2000, 15:373-86

Lonnie Swift

Contact Dr Swift: